IMARC Group, a leading market research company, has recently releases report titled “Mucosal Atomization Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global mucosal atomization devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the mucosal atomization devices market?
The global mucosal atomization devices market size reached US$ 723.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,074.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
What are mucosal atomization devices?
Mucosal atomization devices are drug delivering devices that administer atomized drugs to treat chronic diseases such as allergic rhinitis and sinusitis. These non-invasive devices deliver drugs through the nasal mucosa or nostrils. They consist of syringes and a small-sized atomizing tip at the end of a flexible applicator, partially covered by foam, which turns the medicine into a fine mist. These devices offer superior efficiency and allow rapid absorption of the therapeutics. They are also gaining popularity as an efficient alternative to the traditional needle-based injection drug delivery method as they are safe to use, systematic, painless, and flexible. Consequently, they are used across hospitals, specialized clinics, and ambulatory surgical centers.
Request Free Sample Copy of This Report: https://www.imarcgroup.com/mucosal-atomization-devices-market/requestsample
What are the growth prospects and trends in the mucosal atomization devices industry?
The global mucosal atomization devices market is primarily driven by the increasing demand for non-invasive and effective drug delivery systems that offer quicker recovery and less painful options.
Besides this, there has been widespread adoption of mucosal atomization devices as they help in the faster delivery of medication in the bloodstream and reduce the time of the medicine to act on the concerned medical issue. Nowadays, mucosal atomization devices are commonly available in gas-propelled variants containing highly pressurized nitrogen gas and offering convenient access to large mucosal surfaces, which is favoring the market growth.
In addition, manufacturers are launching auto-disposable variants that are safe and hygienic. Furthermore, the significant growth of the healthcare industry and the implementation of various government initiatives to promote public health is anticipated to facilitate market growth in the upcoming years.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product Type:
- Nasal Atomization Devices
- Fiber-Optic Atomization Devices
- Laryngo-Tracheal Atomization Devices
- Bottle Atomizer Devices
Breakup by Technology:
- Gas Propelled
- Electrical
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Becton Dickinson and Company, DeVilbiss Healthcare LLC (Drive DeVilbiss Healthcare), Kurve Technology Inc., Life-Assist Inc., Medica Holdings LLC, MedTree (BTME Group Ltd.) and Teleflex Incorporated.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
